| P50 | author | Marco Prinz | Q30055422 |
| | Ori Staszewski | Q61799179 |
| P2093 | author name string | Ingo Bechmann | |
| | Martin Krueger | |
| | Wolfgang J Streit | |
| | Wolf Mueller | |
| | Jasmin Tischer | |
| P2860 | cites work | TREM2 Variants in Alzheimer's Disease | Q22250873 |
| | Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 |
| | Microglial pathology | Q26992285 |
| | Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology | Q27327835 |
| | Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 |
| | Of mice and not men: differences between mouse and human immunology | Q28246229 |
| | Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood | Q28292031 |
| | Microglia: active sensor and versatile effector cells in the normal and pathologic brain | Q29547240 |
| | Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 |
| | Microglial physiology: unique stimuli, specialized responses | Q29620417 |
| | Microglia: a sensor for pathological events in the CNS | Q29620556 |
| | TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice | Q33343490 |
| | Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways | Q34035175 |
| | Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis | Q34042034 |
| | Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. | Q34165606 |
| | Host microbiota constantly control maturation and function of microglia in the CNS. | Q34478756 |
| | Microglial senescence: does the brain's immune system have an expiration date? | Q34550017 |
| | TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. | Q35161472 |
| | CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. | Q35213298 |
| | Microglia activation in sepsis: a case-control study | Q35612988 |
| | Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging | Q35809944 |
| | Population control of resident and immigrant microglia by mitosis and apoptosis | Q35916062 |
| | Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences | Q36052653 |
| | Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study | Q36164195 |
| | Microglia: immune network in the CNS. | Q36476799 |
| | Genetic background and the dilemma of translating mouse studies to humans | Q37058617 |
| | The value of incomplete mouse models of Alzheimer's disease | Q37083271 |
| | Debris clearance by microglia: an essential link between degeneration and regeneration. | Q37092476 |
| | Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. | Q37093985 |
| | Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease | Q37331433 |
| | An Association between Immunosenescence and CD4+CD25+ Regulatory T cells: A Systematic Review | Q37799032 |
| | Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function | Q38015663 |
| | T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases | Q38274179 |
| | Altered antigen expression of microglia in the aged rodent CNS. | Q40870393 |
| | Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System | Q41595928 |
| | Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene | Q41832311 |
| | Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. | Q42057034 |
| | Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's disease | Q43555466 |
| | A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity | Q43793656 |
| | Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial | Q44463935 |
| | Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. | Q44557611 |
| | Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia | Q45238725 |
| | Microglia density decreases with age in a mouse model of Huntington's disease. | Q45289720 |
| | Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease | Q45305307 |
| | Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. | Q45881740 |
| | Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. | Q46389933 |
| | Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice | Q46427591 |
| | beta-Amyloid peptides induce degeneration of cultured rat microglia | Q46885770 |
| | Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions | Q46891042 |
| | Dystrophic microglia in the aging human brain | Q48090856 |
| | Immune marker CD68 correlates with cognitive impairment in normally aged rats. | Q48113636 |
| | Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. | Q48215354 |
| | Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. | Q48219387 |
| | Telomere dysfunction reduces microglial numbers without fully inducing an aging phenotype | Q48221187 |
| | Evidence for synaptic stripping by cortical microglia | Q48351803 |
| | Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease | Q48690316 |
| | Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro | Q48830389 |
| | Macrophage biology and immunology: man is not a mouse | Q49922501 |
| | A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. | Q51983154 |
| | Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. | Q53189340 |
| | Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. | Q53312524 |
| | Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease | Q68099264 |
| | Microglia and neuroprotection: implications for Alzheimer's disease | Q81683788 |
| P433 | issue | 9 | |
| P921 | main subject | pathology | Q7208 |
| | Alzheimer's disease | Q11081 |
| | microglia | Q1622829 |
| P304 | page(s) | 1562-1572 | |
| P577 | publication date | 2016-07-12 | |
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | Inhomogeneous distribution of Iba-1 characterizes microglial pathology in Alzheimer's disease | |
| P478 | volume | 64 | |